UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000042227 |
|---|---|
| Receipt number | R000048187 |
| Scientific Title | The genetic background in chronic pain disorders |
| Date of disclosure of the study information | 2020/12/01 |
| Last modified on | 2024/05/28 10:19:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The genetic background in chronic pain disorders
Acronym
The genetic background in chronic pain disorders
Scientific Title
The genetic background in chronic pain disorders
Scientific Title:Acronym
The genetic background in chronic pain disorders
Region
| Japan |
Condition
Condition
chronic pain disorders
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
Exploring the genetic background in chronic pain disorders
Basic objectives2
Others
Basic objectives -Others
Searching for the relationship between gene mutations and clinical symptoms
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Detection of related gene mutations in chronic pain disease
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
People with chronic pain
Key exclusion criteria
Those who do not want to be examined
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Tomohiko |
| Middle name | |
| Last name | Aoe |
Organization
Chiba Medical Center, Teikyo University
Division name
Pain Center
Zip code
299-0111
Address
3426-3 Anesaki, Ichihara City, Chiba 299-0111, Japan.
TEL
0436621211
tomohikoA@med.teikyo-u.ac.jp
Public contact
Name of contact person
| 1st name | Tomohiko |
| Middle name | |
| Last name | Aoe |
Organization
Chiba Medical Center, Teikyo University
Division name
Pain Center
Zip code
299-0111
Address
3426-3 Anesaki, Ichihara City, Chiba 299-0111, Japan.
TEL
0436621211
Homepage URL
tomohikoA@med.teikyo-u.ac.jp
Sponsor or person
Institute
Chiba Medical Center, Teikyo University
Institute
Department
Personal name
Funding Source
Organization
Chiba Medical Center, Teikyo University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Teikyo University Ethical Review Board for Medical and Health Research Involving Human Subjects
Address
2-11-1 Kaga, Itabashi-Ku, Tokyo, Japan
Tel
03-3964-7256
turb-office@teikyo-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
帝京大学ちば総合医療センター
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 12 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
0
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2020 | Year | 07 | Month | 04 | Day |
Date of IRB
| 2020 | Year | 07 | Month | 21 | Day |
Anticipated trial start date
| 2020 | Year | 10 | Month | 26 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
If a family with similar clinical symptoms and suspected genetic involvement in hyperalgesia is observed, a full exon sequence is performed by an external laboratory to detect the mutant gene in the patient.
Management information
Registered date
| 2020 | Year | 10 | Month | 24 | Day |
Last modified on
| 2024 | Year | 05 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048187
